E. coli O157: H7 Vaccine Development

大肠杆菌 O157:H7 疫苗开发

基本信息

  • 批准号:
    8048873
  • 负责人:
  • 金额:
    $ 22.95万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-09-27 至 2013-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Our long-term goal is to develop human vaccines for the prevention of diarrhea and/or HUS caused by E. coli O157:H7 and diarrhea by other pathogenic E. coli. In the currently proposed studies, we will screen the genome of E. coli O157:H7 to identify protective antigens that would become components of a human vaccine, and such approach can be used to protect against pathogenic E. coli infections without affecting commensal flora. The central hypothesis is that identification of protective antigens unique to O157:H7 is a viable approach for development of a vaccine for prevention of diarrhea and Hemolytic Uremic Syndrome episodes. Progress in recent years identifying E. coli O157:H7 novel virulence factors suggest that they can become useful components of a vaccine candidate. Of particular note are those proteins expressed on the bacterial membranes or secreted to the extracellular milieu, which have been previously associated with virulence traits. Therefore, it is plausible to propose that E. coli O157:H7-specific genes can become excellent candidates as components of vaccines. Our proposed experimental approach will focus on two specific aims: Identify the O157-specific gene sequences of E. coli O157:H7 and use them to generate a library of expression constructs optimized for vaccine screening; and determine the protective capacity of O157-specific gene sequence using a murine model of E. coli O157:H7 infection, to identify a subset of subunit vaccine candidates. Our proposal is significant because it is expected to provide the basic knowledge needed to develop an optimal vaccine that will be used to prevent infections caused by E. coli O157:H7, a category B pathogen for its potential use as biothreat agents in food and agriculture, and eventually to treat infections caused by other related pathogenic E. coli strains. PUBLIC HEALTH RELEVANCE: Our objective is to screen the genome of E. coli O157:H7 (category B pathogen) to identify protective antigens that would become components of vaccine candidates in developing a human vaccine.
描述(由申请人提供):我们的长期目标是开发人类疫苗,用于预防由大肠杆菌O157:H7引起的腹泻和/或溶血性尿毒综合征,以及由其他致病性大肠杆菌引起的腹泻。在目前提出的研究中,我们将筛选大肠杆菌O157:H7的基因组,以确定保护性抗原,这些抗原将成为人类疫苗的组成部分,这种方法可用于防止致病性大肠杆菌感染,而不影响共生菌群。中心假设是,鉴定O157:H7特有的保护性抗原是开发预防腹泻和溶血性尿毒症综合征发作的疫苗的可行方法。近年来确定大肠杆菌O157:H7新型毒力因子的进展表明,它们可以成为候选疫苗的有用成分。特别值得注意的是那些在细菌膜上表达或分泌到细胞外环境的蛋白质,这些蛋白质以前与毒力特性有关。因此,我们有理由提出,大肠杆菌O157: h7特异性基因可以成为疫苗组成部分的优秀候选者。我们提出的实验方法将侧重于两个具体目标:鉴定大肠杆菌O157:H7的O157特异性基因序列,并利用它们生成用于疫苗筛选优化的表达构建体文库;并利用大肠杆菌O157:H7感染小鼠模型确定O157特异性基因序列的保护能力,以确定亚单位候选疫苗的一个亚群。我们的建议意义重大,因为它有望提供开发最佳疫苗所需的基本知识,用于预防由大肠杆菌O157:H7引起的感染,并最终治疗由其他相关致病性大肠杆菌菌株引起的感染。大肠杆菌O157:H7是一种B类病原体,可能在食品和农业中用作生物威胁剂。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Alfredo G Torres其他文献

Alfredo G Torres的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Alfredo G Torres', 18)}}的其他基金

Developing effective nanovaccines against pathogenic Escherichia coli
开发针对致病性大肠杆菌的有效纳米疫苗
  • 批准号:
    10413247
  • 财政年份:
    2021
  • 资助金额:
    $ 22.95万
  • 项目类别:
Developing effective nanovaccines against pathogenic Escherichia coli
开发针对致病性大肠杆菌的有效纳米疫苗
  • 批准号:
    10300897
  • 财政年份:
    2021
  • 资助金额:
    $ 22.95万
  • 项目类别:
Defining the role of toxin-antitoxin systems in persistence of Burkholderia pseudomallei
定义毒素-抗毒素系统在类鼻疽伯克霍尔德杆菌持久性中的作用
  • 批准号:
    10194359
  • 财政年份:
    2020
  • 资助金额:
    $ 22.95万
  • 项目类别:
Glycoconjugate Nanoparticle Vaccines Against Burkholderia Infections
针对伯克霍尔德氏菌感染的糖复合物纳米颗粒疫苗
  • 批准号:
    9186787
  • 财政年份:
    2016
  • 资助金额:
    $ 22.95万
  • 项目类别:
Glycoconjugate Nanoparticle Vaccines Against Burkholderia Infections
针对伯克霍尔德氏菌感染的糖复合物纳米颗粒疫苗
  • 批准号:
    9282736
  • 财政年份:
    2016
  • 资助金额:
    $ 22.95万
  • 项目类别:
Vaccine Development for Burkholderia amllei and B. pseudomallei
鼻疽伯克霍尔德杆菌和类鼻疽伯克霍尔德杆菌的疫苗开发
  • 批准号:
    8377054
  • 财政年份:
    2012
  • 资助金额:
    $ 22.95万
  • 项目类别:
E. coli O157: H7 Vaccine Development
大肠杆菌 O157:H7 疫苗开发
  • 批准号:
    8339440
  • 财政年份:
    2011
  • 资助金额:
    $ 22.95万
  • 项目类别:
Long Polar Fimbriae of Attaching and Effacing Escherichia coli
附着和消除大肠杆菌的长极菌毛
  • 批准号:
    7846683
  • 财政年份:
    2009
  • 资助金额:
    $ 22.95万
  • 项目类别:
Long Polar Fimbriae of Attaching and Effacing Escherichia coli
附着和消除大肠杆菌的长极菌毛
  • 批准号:
    7795038
  • 财政年份:
    2009
  • 资助金额:
    $ 22.95万
  • 项目类别:
Long Polar Fimbriae of Attaching and Effacing Escherichia coli
附着和消除大肠杆菌的长极菌毛
  • 批准号:
    7662935
  • 财政年份:
    2009
  • 资助金额:
    $ 22.95万
  • 项目类别:

相似海外基金

How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
  • 批准号:
    BB/Z514391/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.95万
  • 项目类别:
    Training Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
  • 批准号:
    2312555
  • 财政年份:
    2024
  • 资助金额:
    $ 22.95万
  • 项目类别:
    Standard Grant
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
  • 批准号:
    2327346
  • 财政年份:
    2024
  • 资助金额:
    $ 22.95万
  • 项目类别:
    Standard Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
  • 批准号:
    ES/Z502595/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.95万
  • 项目类别:
    Fellowship
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
  • 批准号:
    23K24936
  • 财政年份:
    2024
  • 资助金额:
    $ 22.95万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
  • 批准号:
    ES/Z000149/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.95万
  • 项目类别:
    Research Grant
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
  • 批准号:
    2901648
  • 财政年份:
    2024
  • 资助金额:
    $ 22.95万
  • 项目类别:
    Studentship
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
  • 批准号:
    488039
  • 财政年份:
    2023
  • 资助金额:
    $ 22.95万
  • 项目类别:
    Operating Grants
New Tendencies of French Film Theory: Representation, Body, Affect
法国电影理论新动向:再现、身体、情感
  • 批准号:
    23K00129
  • 财政年份:
    2023
  • 资助金额:
    $ 22.95万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The Protruding Void: Mystical Affect in Samuel Beckett's Prose
突出的虚空:塞缪尔·贝克特散文中的神秘影响
  • 批准号:
    2883985
  • 财政年份:
    2023
  • 资助金额:
    $ 22.95万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了